ESM1, also known as endocan, has been shown to regulate endothelial cell function in the initiation and progression of human cancers, including esophageal cancer, hepatocellular carcinoma, bladder cancer, and breast cancer (22). This evidence concerns the gene ESM1 and breast cancer.